Twelve Month Follow-Up of CP0108

Completed

Conditions studied: Actinic Keratosis

In brief

The purpose of this study is to determine the long-term safety and efficacy of Levulan PDT in subjects with multiple actinic keratosis of the upper extremities who received treatment as part of the DUSA CP0108 study.

Key facts

Study ID

NCT02209012

Run by

DUSA Pharmaceuticals, Inc.

People needed

206

Starts

2014-08-01

Expected to finish

2016-04-01

Last updated by the study team

2016-09-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject must have been enrolled in the DUSA-CP0108 study, completed their assigned treatment and Visit 6 (Week 12).

Where it is running

• Center For Dermatology Clinical Research, Inc. — Fremont, California, United States
• UCSD Dermatology — San Diego, California, United States
• Center for Clinical and Cosmetic Research — Aventura, Florida, United States
• MOORE Clinical Research, Inc — Brandon, Florida, United States
• Spencer Clinical Services — St. Petersburg, Florida, United States
• Altman Dermatology Associates — Arlington Heights, Illinois, United States
• Shideler Clinical Research Center — Carmel, Indiana, United States
• The Indiana Clinical Trials Center, PC — Plainfield, Indiana, United States
• Minnesota Clinical Study Center — Fridley, Minnesota, United States
• Oregon Dermatology and Research Center — Portland, Oregon, United States
• J&S Studies, Inc — College Station, Texas, United States
• Suzanne Bruce and Associates, P.A.,The Center for Skin Research — Houston, Texas, United States
• Virginia Clinical Research, Inc. — Norfolk, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.